Metabolic waste proteins such as amyloid, tau, and synuclein can be targets for the clearance of glymphatic pathway and its impairments can lead to pathologic accumulation in the brain leading to neurodegenerative diseases such as AD, Parkinson’s disease, and traumatic brain encephalopathy [14–17]. This evidence concerns the gene MAPT and neurodegenerative disease.